Meet the Speakers

Speakers


2020 Webinar Speakers Include:


Dr. Philipp Schlatter
Dr. Philipp Schlatter
Community of Practice Leader, Post Trial Access & Drug Supply
Roche
Karen Frascello
Karen Frascello
Director, Global Medical Affairs, Early Access
Alnylam Pharmaceuticals
Holly Lumgair
Holly Lumgair
Patient Advocacy
Clinigen Group
Gregory Tuyteleers
Gregory Tuyteleers
Global Operations Lead - Managed Access
Janssen
Dennis Akkaya
Dennis Akkaya
Corporate Development
myTomorrows
Alison Bateman-House
Alison Bateman-House
Co-Chair
NYU Working Group on Compassionate Use and Preapproval Access (CUPA)
Jean Godin
Jean Godin
Global Head of Humanitarian Aid and Managed Access Programs
Sanofi Genzyme
Paul Aliu
Paul Aliu
Head Global Governance Office, Chief Medical Office
Novartis
Christine MacCracken
Christine MacCracken
Director, Patient Strategies & Solutions, Office of the Chief Medical Officer
Janssen
Kenneth Moch
Kenneth Moch
President & CEO
Cognition Therapeutics and CUPA Member
Pat Furlong
Pat Furlong
Founding President & CEO
Parent Project Muscular Dystrophy (PPMD) and CUPA Member
Hayley Belli
Hayley Belli
Assistant Professor, Biostatistics Division, Department of Population Health
New York University School of Medicine
Graham Sidorowicz
Graham Sidorowicz
VP Business Development - Early Access Programs
Bionical Emas
Geoff Fatzinger PhD
Geoff Fatzinger PhD
Managing Director CCPS UK, Global VP QA/RA and Strategic Services
Caligor Coghlan Pharma Services
Torunn Thingstad
Torunn Thingstad
Director, Global Program Leader - Managed Access
Janssen
Veronique Ollivier-Guillon
Veronique Ollivier-Guillon
Director, Global Program Leader - Managed Access
Janssen
Bettina Ryll
Bettina Ryll
Founder
Melanoma Patient Network Europe
Jodi Wolff
Jodi Wolff
Head of Patient Advocacy US
Santhera
Raj Nijjar
Raj Nijjar
Clinical Lead Cancer Pharmacist & Specialised Cancer Commissioning Pharmacist
Barts Health NHS Trust & NHS England - London Region